Display options
Share it on

Cancers (Basel). 2021 May 23;13(11). doi: 10.3390/cancers13112554.

2-[.

Cancers

Aida Sabaté-Llobera, Judit Mestres-Martí, Gabriel Reynés-Llompart, Laura Lladó, Kristel Mils, Teresa Serrano, Montserrat Cortés-Romera, Esther Bertran, Isabel Fabregat, Emilio Ramos

Affiliations

  1. PET Unit, Department of Nuclear Medicine-IDI, University Hospital of Bellvitge, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  2. Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  3. Department of Medical Physics, Catalan Institute of Oncology, Duran i Reynals Hospital, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  4. Faculty of Medicine and Health Sciences, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  5. Hepato-Biliary, Pancreatic and Liver Transplantation Unit, Department of Surgery, University Hospital of Bellvitge, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  6. Department of Pathology, University Hospital of Bellvitge, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  7. Oncology Program, Centro de Investigación Biomédica en Red, Enfermedades Hepáticas y Digestivas (CIBEREHD), National Biomedical Research Institute on Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III, 28029 Madrid, Spain.
  8. TGF-ß and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

PMID: 34070953 PMCID: PMC8196959 DOI: 10.3390/cancers13112554

Abstract

Hepatocellular carcinoma (HCC) generally presents a low avidity for 2-deoxy-2-[

Keywords: 2-[18F]FDG; PET/CT; cellular differentiation.; hepatocellular carcinoma; lean body mass; liver resection; microvascular invasion; standardized uptake value

References

  1. World J Gastroenterol. 2014 May 28;20(20):5935-50 - PubMed
  2. Ann Hepatobiliary Pancreat Surg. 2017 Nov;21(4):194-198 - PubMed
  3. J Nucl Med. 1995 Oct;36(10):1811-7 - PubMed
  4. AJR Am J Roentgenol. 2014 Sep;203(3):W253-9 - PubMed
  5. J Nucl Med. 1978 Oct;19(10):1154-61 - PubMed
  6. HPB (Oxford). 2019 Jun;21(6):739-747 - PubMed
  7. Hepatology. 2018 Jan;67(1):358-380 - PubMed
  8. Hepatology. 2016 Mar;63(3):839-49 - PubMed
  9. World J Gastroenterol. 2019 Mar 21;25(11):1289-1306 - PubMed
  10. Eur Radiol. 2020 Oct;30(10):5348-5357 - PubMed
  11. Diagn Interv Radiol. 2016 Mar-Apr;22(2):125-32 - PubMed
  12. Abdom Imaging. 2015 Apr;40(4):843-51 - PubMed
  13. Semin Liver Dis. 2005;25(2):181-200 - PubMed
  14. Front Oncol. 2020 Jun 26;10:887 - PubMed
  15. Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):28-37 - PubMed
  16. Eur J Nucl Med Mol Imaging. 2018 May;45(5):720-726 - PubMed
  17. Sci Rep. 2019 Jul 23;9(1):10640 - PubMed
  18. Front Oncol. 2021 Mar 03;11:633596 - PubMed
  19. J Hepatol. 2015 Jul;63(1):83-92 - PubMed
  20. Hepatology. 2008 Jan;47(1):97-104 - PubMed
  21. J Comput Assist Tomogr. 2016 Jul-Aug;40(4):524-30 - PubMed
  22. Liver Transpl. 2015 May;21(5):572-80 - PubMed
  23. Hepatogastroenterology. 2003 Nov-Dec;50(54):2154-6 - PubMed
  24. CA Cancer J Clin. 2021 May;71(3):209-249 - PubMed
  25. Radiology. 1999 Nov;213(2):521-5 - PubMed
  26. Eur J Nucl Med Mol Imaging. 2016 May;43(5):852-859 - PubMed
  27. Clin Nucl Med. 2016 Mar;41(3):e126-9 - PubMed
  28. Nucl Med Commun. 2018 Jun;39(6):564-571 - PubMed
  29. Ann Surg. 2002 Mar;235(3):373-82 - PubMed
  30. Br J Surg. 2016 Jun;103(7):881-90 - PubMed
  31. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):294-301 - PubMed

Publication Types

Grant support